Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Alviumeel 4 D Liquid is a Health Canada–registered human drug (DIN 02236485) held by Biologische Heilmittel Heel GmbH, containing Ambra Grisea. Health Canada lists its status as Cancelled Post Market (status date 19 Jul 2002). Nexara Health has matched 3 registrations of Ambra Grisea across 2 other regulated markets.

Health Canada registration

DIN02236485
Brand nameAlviumeel
Active ingredientAmbra Grisea
Strength4 D
Dosage formLiquid
RouteOral
CompanyBiologische Heilmittel Heel GmbH
StatusCancelled Post Market — 19 Jul 2002
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Ambra Grisea registered in other markets

3 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
NetherlandsAmbra griseaBOIRON (Messimy)8 DH t/m 60 DH#4 CH t/m 200 CH#7 K t/m 100.000K#Uitsluitend apotheek of drogistEU national register
NetherlandsAmbra griseaBOIRON (Messimy)8 DH t/m 60 DH#4 CH t/m 200 CH#7 K t/m 100.000K#GlobuliUitsluitend apotheek of drogistEU national register
United StatesBmnp Ambra GriseaTotal Operations Management LLC DBA:Bestmade Natural Products MicroGlobulelistedFDA NDC

See every manufacturer of Ambra Grisea worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Alviumeel (DIN 02236485) marketed in Canada?

No. Health Canada lists DIN 02236485 as Cancelled Post Market as of 19 Jul 2002.

Who holds the Canadian licence for this product?

Biologische Heilmittel Heel GmbH is the company of record in the Health Canada Drug Product Database.

Is Ambra Grisea registered outside Canada?

Yes — Nexara Health has matched 3 registrations in 2 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02236485, status date 2002-07-19; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02236485, status date 2002-07-19; national medicine registries: EU national register, FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02236485, status date 2002-07-19; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.